Position in BTAI
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$29,164
New position
Shares Held
20,684
first reported quarter
Ownership
0.066%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 46 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026StoneX Group Inc. holds $522,938 across 7 Drug Manufacturers - Specialty & Generic names. BTAI ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,713 | $266,816 | |
| 2 | HCM |
HUTCHMED (China) Ltd
|
18,262 | $196,499 | |
| 3 | BTAI |
BioXcel Therapeutics, Inc.
This page
|
20,684 | $29,164 | |
| 4 | OGI |
Organigram Global Inc.
|
17,630 | $17,982 | |
| 5 | YCBD |
cbdMD, Inc.
|
12,732 | $8,568 | |
| 6 | IMCC |
IM Cannabis Corp.
|
774 | $3,909 | |
| 7 | 17,537 | $0 |
All Filings in BTAI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,164 | 20,684 | Shares | Defined | 2026-08-12 | |
| No filing history on record for this holder in this stock. | ||||||